Portal de Periódicos da CAPES

Methamphetamine Quantitative Urine Concentrations during a Controlled Trial of Fluoxetine Treatment: Preliminary Analysis

2000; Wiley; Volume: 909; Issue: 1 Linguagem: Inglês

10.1111/j.1749-6632.2000.tb06688.x

1749-6632

Steven L. Batki, Jessica J. Moon, Kevin Delucchi, M.S. Bradley, Deborah Hersh, S. Smolar, Matilda M. Mengis, Eli Lefkowitz, D. SEXE, Lauren Morello, Tom Everhart, R. T. Jones, Peyton Jacob,

Mental Health Research Topics

Annals of the New York Academy of SciencesVolume 909, Issue 1 p. 260-263 Methamphetamine Quantitative Urine Concentrations during a Controlled Trial of Fluoxetine Treatment: Preliminary Analysis S. L. BATKI, Corresponding Author S. L. BATKI State University of New York Upstate Medical University at Syracuse, Department of Psychiatry, Syracuse, New York 13210, USAb Address for correspondence: Steven L. Batki, M.D., SUNY Upstate Medical University at Syracuse, Department of Psychiatry, 750 East Adams St., Syracuse, NY. (At the time of this study, Dr. Batki was affiliated with UCSF.) e-mail: batkis@upstate.eduSearch for more papers by this authorJ. MOON, J. MOON University of California, San Francisco, Department of Psychiatry, San Francisco, California 94143, USA San Francisco General Hospital, Division of Substance Abuse and Addiction Medicine, San Francisco, California 94110, USASearch for more papers by this authorK. DELUCCHI, K. DELUCCHI University of California, San Francisco, Department of Psychiatry, San Francisco, California 94143, USASearch for more papers by this authorM. BRADLEY, M. BRADLEY University of California, San Francisco, Department of Psychiatry, San Francisco, California 94143, USA San Francisco General Hospital, Division of Substance Abuse and Addiction Medicine, San Francisco, California 94110, USASearch for more papers by this authorD. HERSH, D. HERSH University of California, San Francisco, Department of Psychiatry, San Francisco, California 94143, USA San Francisco General Hospital, Division of Substance Abuse and Addiction Medicine, San Francisco, California 94110, USASearch for more papers by this authorS. SMOLAR, S. SMOLAR University of California, San Francisco, Department of Psychiatry, San Francisco, California 94143, USA San Francisco General Hospital, Division of Substance Abuse and Addiction Medicine, San Francisco, California 94110, USASearch for more papers by this authorM. MENGIS, M. MENGIS University of California, San Francisco, Department of Psychiatry, San Francisco, California 94143, USA San Francisco General Hospital, Division of Substance Abuse and Addiction Medicine, San Francisco, California 94110, USASearch for more papers by this authorE. LEFKOWITZ, E. LEFKOWITZ University of California, San Francisco, Department of Psychiatry, San Francisco, California 94143, USA San Francisco General Hospital, Division of Substance Abuse and Addiction Medicine, San Francisco, California 94110, USASearch for more papers by this authorD. SEXE, D. SEXE University of California, San Francisco, Department of Psychiatry, San Francisco, California 94143, USA San Francisco General Hospital, Division of Substance Abuse and Addiction Medicine, San Francisco, California 94110, USASearch for more papers by this authorL. MORELLO, L. MORELLO University of California, San Francisco, Department of Psychiatry, San Francisco, California 94143, USA San Francisco General Hospital, Division of Substance Abuse and Addiction Medicine, San Francisco, California 94110, USASearch for more papers by this authorT. EVERHART, T. EVERHART University of California, San Francisco, Department of Psychiatry, San Francisco, California 94143, USASearch for more papers by this authorR. T. JONES, R. T. JONES University of California, San Francisco, Department of Psychiatry, San Francisco, California 94143, USASearch for more papers by this authorP. JACOB III, P. JACOB III University of California, San Francisco, Department of Psychiatry, San Francisco, California 94143, USASearch for more papers by this author S. L. BATKI, Corresponding Author S. L. BATKI State University of New York Upstate Medical University at Syracuse, Department of Psychiatry, Syracuse, New York 13210, USAb Address for correspondence: Steven L. Batki, M.D., SUNY Upstate Medical University at Syracuse, Department of Psychiatry, 750 East Adams St., Syracuse, NY. (At the time of this study, Dr. Batki was affiliated with UCSF.) e-mail: batkis@upstate.eduSearch for more papers by this authorJ. MOON, J. MOON University of California, San Francisco, Department of Psychiatry, San Francisco, California 94143, USA San Francisco General Hospital, Division of Substance Abuse and Addiction Medicine, San Francisco, California 94110, USASearch for more papers by this authorK. DELUCCHI, K. DELUCCHI University of California, San Francisco, Department of Psychiatry, San Francisco, California 94143, USASearch for more papers by this authorM. BRADLEY, M. BRADLEY University of California, San Francisco, Department of Psychiatry, San Francisco, California 94143, USA San Francisco General Hospital, Division of Substance Abuse and Addiction Medicine, San Francisco, California 94110, USASearch for more papers by this authorD. HERSH, D. HERSH University of California, San Francisco, Department of Psychiatry, San Francisco, California 94143, USA San Francisco General Hospital, Division of Substance Abuse and Addiction Medicine, San Francisco, California 94110, USASearch for more papers by this authorS. SMOLAR, S. SMOLAR University of California, San Francisco, Department of Psychiatry, San Francisco, California 94143, USA San Francisco General Hospital, Division of Substance Abuse and Addiction Medicine, San Francisco, California 94110, USASearch for more papers by this authorM. MENGIS, M. MENGIS University of California, San Francisco, Department of Psychiatry, San Francisco, California 94143, USA San Francisco General Hospital, Division of Substance Abuse and Addiction Medicine, San Francisco, California 94110, USASearch for more papers by this authorE. LEFKOWITZ, E. LEFKOWITZ University of California, San Francisco, Department of Psychiatry, San Francisco, California 94143, USA San Francisco General Hospital, Division of Substance Abuse and Addiction Medicine, San Francisco, California 94110, USASearch for more papers by this authorD. SEXE, D. SEXE University of California, San Francisco, Department of Psychiatry, San Francisco, California 94143, USA San Francisco General Hospital, Division of Substance Abuse and Addiction Medicine, San Francisco, California 94110, USASearch for more papers by this authorL. MORELLO, L. MORELLO University of California, San Francisco, Department of Psychiatry, San Francisco, California 94143, USA San Francisco General Hospital, Division of Substance Abuse and Addiction Medicine, San Francisco, California 94110, USASearch for more papers by this authorT. EVERHART, T. EVERHART University of California, San Francisco, Department of Psychiatry, San Francisco, California 94143, USASearch for more papers by this authorR. T. JONES, R. T. JONES University of California, San Francisco, Department of Psychiatry, San Francisco, California 94143, USASearch for more papers by this authorP. JACOB III, P. JACOB III University of California, San Francisco, Department of Psychiatry, San Francisco, California 94143, USASearch for more papers by this author First published: 25 January 2006 https://doi.org/10.1111/j.1749-6632.2000.tb06688.xCitations: 18Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Citing Literature Volume909, Issue1NEW MEDICATIONS FOR DRUG ABUSEJanuary 2000Pages 260-263 RelatedInformation